Malaysia’s National Immunization Programme (NIP) chose Pfizer, AstraZeneca (AZ) and Sinovac as its vaccine portfolio. At the outset,…

This policy brief assesses COVID-19’s impact on travel and tourism in Asia and the Pacific and outlines a set of expert-reviewed policy…

In order to keep abreast of emerging issues at the National/International and local level, the SDPI brings out a Bi-weekly E-Newsletter…

The full re-opening of land borders between Johor and Singapore is critical for Johor’s recovery and is in the interest of both…

This paper provides an overview of early childhood development in the People’s Republic of China and calls for a comprehensive and…

This report discusses the key factors for the successful response of the Republic of Korea to coronavirus disease (COVID-19) and…

Malaysia’s policy responses, launched under the various COVID-19 stimulus packages, have prioritized the retention of the existing…

A half-yearly compilation of the latest activities and publications of the NTS-Asia Consortium

New variants of the coronavirus are producing the worst outbreaks in many countries in the Indo-Pacific. Progress with vaccine rollouts…

Before the 1990s, Mongolia had a health care system that largely depended on hospital-based services. The country’s hospital sector was…